BEYONTTRA
Live / Allowed — Published for opposition (as of 24 Feb 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 25 Sept 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99413643
- Mark type
- Stylized text
- Filed
- 25 Sept 2025
- Published for opposition
- 24 Feb 2026
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for use in the treatment of oncological, cardiological, dermatological, neurological, genetic, orthopedic and metabolic diseases and disorders
Owner
- BridgeBio Pharma, Inc., Palo Alto, CA, US
- BridgeBio Pharma, Inc., Palo Alto, CA, US
Prosecution history
- 24 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Feb 2026 — PUBLISHED FOR OPPOSITION
- 18 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Feb 2026 — ASSIGNED TO EXAMINER
- 25 Sept 2025 — APPLICATION FILING RECEIPT MAILED
- 25 Sept 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 25 Sept 2025 — NEW APPLICATION ENTERED